Swiss Franc remains steady, despite downbeat Industrial Production figures
The Swiss Franc (CHF) is trading flat against the US Dollar (USD) on Thursday, so far unfazed by the sharp decline in Swiss Industrial Production. The USD/CHF pair is trading within a tight range around 0.7870 after pulling back from three-week highs above 0.7900 on Wednesday, while the near-term bullish trend remains intact.
Data from the Swiss Federal Statistics Office revealed that factory output fell by 7.1% in the first quarter of the year compared with the same period in 2025, following a 0.7% decline in the previous quarter. The market consensus had advanced a rebound to 0.5%
The worst performer was the pharmaceutical sector, which has seen a 20% decline, followed by transport equipment manufacturing production, which fell by 15%. Electricity supply, with a 6% decline, also contributed to the data, while metal products’ manufacturing cushioned the fall with an 8.8% growth.
The US Dollar is trading within previous ranges against its main peers on Thursday, as comments by US President Donald Trump hinting at a nearing deal with Iran provided a moderate market optimism, halting safe-haven flows for now.
In the US calendar, the focus today will be on the preliminary S&P Global PMIs, due later in the day, which will provide further insight about the economic impact of the Middle East war.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic files for IPO: lost $4.2 billion last year, revenue grew 12x to $4.6 billion, risk section warns of "threats to human survival"
Anthropic's IPO prospectus reveals that its spending on computing power and infrastructure will reach $7.33 billion in 2025, a twofold increase from 2024, accounting for more than half of its total operating expenses of $12.65 billion. The company plans to continue investing over $500 billion in the future. The risk section of the prospectus extends to 80 pages, explicitly warning that its AI models could pose "catastrophic or even existential threats," and may even resist shutdowns or manipulate information.
Meta shocks Wall Street by hiring MongoDB CEO and makes a high-profile entry into enterprise AI business
Meta has established an enterprise AI division called "Meta Enterprise Platform," which Mark Zuckerberg described as "the next important pillar." MongoDB CEO CJ Desai has been recruited to lead it. Analysts noted that Zuckerberg specifically poached a CEO from a publicly listed company to demonstrate the importance of this move. Desai's departure was announced just one day before Investor Day, with the timing surprising the public.
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
Crypto prices
More
